Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Interactive app allows users to explore data underlying estimates of global AMR burden

Map of the world showing AMR prevalence and mortality

Providing a closer snapshot of health loss linked to antimicrobial resistance (AMR), the Global Research on Antimicrobial Resistance (GRAM) Project, has released a visualization tool that measures worldwide AMR burden and related metrics—including pathogen and infectious syndrome deaths—by country, age, bacteria and antibiotic.

The tool, released by the GRAM partnership between the Institute for Health Metrics and Evaluation (IHME) and the University of Oxford, follows the team’s January report which estimated that bacterial AMR caused more than 1.2 million deaths in 2019. Read the study, ‘Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis’, in the Lancet.

Supported by the UK Fleming Fund, the Wellcome Trust, and the Bill and Melinda Gates Foundation, the GRAM findings described AMR as a leading cause of death, and an urgent problem in both low- and high-resource settings. Data collected by GRAM, and analyzed using methodologies from IHME’s ongoing Global Burden of Disease study, represent one of the most comprehensive AMR datasets available, with 471 million separate records.

The tool allows users to generate maps, graphs and other data collected by GRAM, including those showing AMR prevalence and mortality in 204 countries, and for 88 pathogen-and-antibiotic combinations.

In addition to resistance, the tool also allows viewers to explore estimates that researchers used to calculate the burden of AMR, including data on infectious syndromes and bacterial infections.

Users may review deaths and disability adjusted life years (DALYs) for seven infectious syndromes—including bloodstream and lower respiratory infections—by age and sex. The tool also lists deaths and DALYs by pathogen, including 33 bacteria, and several viruses and fungi.

GRAM researchers have cited lack of available data as a key limitation of their research. Indeed, limited data is available for many parts of the world, particularly low- and middle-income settings, where the estimated burden of AMR is greatest.   

Similar stories

Meta-analysis informed the updated WHO guidelines for treatment of uncomplicated malaria in the first trimester of pregnancy

A new WWARN meta-analysis, commissioned by the World Health Organization and which informed a change to its treatment guidelines, has been published in The Lancet. The study provides compelling evidence that artemether-lumefantrine should now replace quinine as the treatment of choice in the first trimester.

Bacterial infections linked to one in eight global deaths, according to GRAM study

Data showing 7.7 million deaths from 33 bacterial infections can guide measures to strengthen health systems, particularly in low-income settings

MQRG team delivers training in Mozambique and Ghana

IDDO’s Medicine Quality Research Group delivered in-person training in researchers in Mozambique and Ghana to support a study into the quality of three antibiotics.

Studying the MSc IHTM 2022/23

MSc IHTM sets out to attract individuals from low resource contexts who are looking to gain the skills and experience to help shape global health in the future. This year 23 students make up the cohort bringing the running total over the eight years of the course to 175 students from 56 countries, the majority of which are LMICs.

The University of Oxford launches fully online Postgraduate Diploma in Global Health Research to tackle inequities in health research leadership

Beginning in October 2023, the Postgraduate Diploma in Global Health Research is specifically targeted at researchers and clinicians in low income countries, and will offer accessibility never previously available. It is the University’s first academic qualification designed to be taken wholly online and will transform Oxford’s ability to reach and train researchers in the most challenging of settings. By removing this significant barrier to access, the postgraduate diploma aims to strengthen health workforces’ research capacity, regardless of location and context, to meet ongoing and emerging global health challenges and crises.

Building Health Research Capacity in Seychelles through strengthened Collaboration

The MSc IHTM is committed to leading positive change in low resource contexts. The aim of the course is to provide students with the skills and opportunities to collaborate across cultural and disciplinary boundaries to identify and develop creative solutions for existing and emerging national, regional and/or global health challenges. A recent example of the impact of the MSc has been an initiative in Seychelles, where a partnership has been established between the MSc IHTM and the Seychelles Ministry of Health (MoH).